NODAL T-FOLLICULAR HELPER CELL LYMPHOMA

Clinical trials for NODAL T-FOLLICULAR HELPER CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new NODAL T-FOLLICULAR HELPER CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for NODAL T-FOLLICULAR HELPER CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for seniors with rare blood cancer: gentler chemo shows promise

Disease control Not yet recruiting

This study tests a new chemotherapy combination called CAOP for elderly patients (65+) with a rare type of lymphoma called peripheral T-cell lymphoma (PTCL). The goal is to see if replacing a standard drug with a less heart-toxic one can still effectively control the cancer while…

Matched conditions: NODAL T-FOLLICULAR HELPER CELL LYMPHOMA

Phase: PHASE2 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control

Last updated May 17, 2026 04:00 UTC

NODAL T-FOLLICULAR HELPER CELL LYMPHOMA

Get alerted when new NODAL T-FOLLICULAR HELPER CELL LYMPHOMA trials appear

New hope for seniors with rare blood cancer: gentler chemo shows promise